South Korea · Delayed Price · Currency is KRW Cha AI Healthcare Statistics
Total Valuation
KRX:025620 has a market cap or net worth of KRW 92.42 billion. The enterprise value is 117.90 billion.
| Market Cap | 92.42B |
| Enterprise Value | 117.90B |
Important Dates
The next estimated earnings date is Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:025620 has 18.19 million shares outstanding. The number of shares has increased by 145.72% in one year.
| Current Share Class | 18.19M |
| Shares Outstanding | 18.19M |
| Shares Change (YoY) | +145.72% |
| Shares Change (QoQ) | +48.11% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | n/a |
| Float | 3.66M |
Valuation Ratios
The trailing PE ratio is 8.83.
| PE Ratio | 8.83 |
| Forward PE | n/a |
| PS Ratio | 10.96 |
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 14.48 |
| EV / Sales | 13.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.58, with a Debt / Equity ratio of 0.50.
| Current Ratio | 0.58 |
| Quick Ratio | 0.40 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | -6.65 |
| Interest Coverage | -2.66 |
Financial Efficiency
Return on equity (ROE) is 13.51% and return on invested capital (ROIC) is -11.64%.
| Return on Equity (ROE) | 13.51% |
| Return on Assets (ROA) | -5.96% |
| Return on Invested Capital (ROIC) | -11.64% |
| Return on Capital Employed (ROCE) | -10.13% |
| Weighted Average Cost of Capital (WACC) | -1.27% |
| Revenue Per Employee | 191.70M |
| Profits Per Employee | 185.09M |
| Employee Count | 44 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 2.13 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.78% in the last 52 weeks. The beta is -1.59, so KRX:025620's price volatility has been lower than the market average.
| Beta (5Y) | -1.59 |
| 52-Week Price Change | -35.78% |
| 50-Day Moving Average | 5,749.00 |
| 200-Day Moving Average | 9,316.80 |
| Relative Strength Index (RSI) | 49.23 |
| Average Volume (20 Days) | 20,345 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:025620 had revenue of KRW 8.43 billion and earned 8.14 billion in profits. Earnings per share was 575.01.
| Revenue | 8.43B |
| Gross Profit | 2.32B |
| Operating Income | -8.23B |
| Pretax Income | 8.16B |
| Net Income | 8.14B |
| EBITDA | -7.38B |
| EBIT | -8.23B |
| Earnings Per Share (EPS) | 575.01 |
Balance Sheet
The company has 15.26 billion in cash and 40.74 billion in debt, with a net cash position of -25.48 billion or -1,400.38 per share.
| Cash & Cash Equivalents | 15.26B |
| Total Debt | 40.74B |
| Net Cash | -25.48B |
| Net Cash Per Share | -1,400.38 |
| Equity (Book Value) | 81.00B |
| Book Value Per Share | 4,454.37 |
| Working Capital | -16.79B |
Cash Flow
In the last 12 months, operating cash flow was -6.01 billion and capital expenditures -119.54 million, giving a free cash flow of -6.13 billion.
| Operating Cash Flow | -6.01B |
| Capital Expenditures | -119.54M |
| Depreciation & Amortization | 803.12M |
| Net Borrowing | 38.40B |
| Free Cash Flow | -6.13B |
| FCF Per Share | -336.69 |
Margins
Gross margin is 27.56%, with operating and profit margins of -97.58% and 96.55%.
| Gross Margin | 27.56% |
| Operating Margin | -97.58% |
| Pretax Margin | 96.73% |
| Profit Margin | 96.55% |
| EBITDA Margin | -87.52% |
| EBIT Margin | -97.58% |
| FCF Margin | n/a |
Dividends & Yields
KRX:025620 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -145.72% |
| Shareholder Yield | -145.72% |
| Earnings Yield | 8.81% |
| FCF Yield | -6.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 25, 2022. It was a reverse split with a ratio of 0.05.
| Last Split Date | Nov 25, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
KRX:025620 has an Altman Z-Score of 0.02 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.02 |
| Piotroski F-Score | 1 |